SCHEMBL9546403

SCHEMBL9546403

CCCCCC/C=C/C1C=C(S(C)(=O)=O)C(=O)/C1=C\CCCCCC(=O)OC

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 2/20 0.42
▸ ALOX5 P09917 3/20 0.40
▸ OXER1 Q8TDS5 1/20 0.39
▸ CNR2 P34972 1/20 0.37
▸ ABHD16A O95870 1/20 0.37
▸ CNR1 P21554 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ PGR P06401 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ ABCC4 O15439 1/20 0.36
▸ ABCB11 O95342 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9546405 1.00 EPHX2 (0.42) EPHX2ALOX5OXER1CNR2ABHD16A
SCHEMBL9546209 0.88 PTGER3 (0.43) ABHD16AALDH1A1
SCHEMBL9546205 0.88 PTGER3 (0.43) ABHD16AALDH1A1
SCHEMBL10607035 0.85 EPHX2 (0.44) EPHX2ALOX5OXER1CNR2ABHD16A
SCHEMBL10603886 0.85 EPHX2 (0.44) EPHX2ALOX5OXER1CNR2ABHD16A
SCHEMBL10607027 0.85 EPHX2 (0.44) EPHX2ALOX5OXER1CNR2ABHD16A
SCHEMBL10603256 0.85 EPHX2 (0.44) EPHX2ALOX5OXER1CNR2ABHD16A
SCHEMBL10603261 0.85 EPHX2 (0.44) EPHX2ALOX5OXER1CNR2ABHD16A
SCHEMBL10607071 0.85 EPHX2 (0.44) EPHX2ALOX5OXER1CNR2ABHD16A
SCHEMBL10603889 0.85 EPHX2 (0.44) EPHX2ALOX5OXER1CNR2ABHD16A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0338796-B1 2-SUBSTITUTED-2-CYCLOPENTENONES TEIJIN LIMITED (JP) 1993-03-10 — — EP disclosed
US-5116869-A Antitumor Agents, Bone Formation Accelerator TEIJIN LIMITED (JP) 1992-05-26 — — US disclosed
Send feedback